Diagnosing Obstructive Sleep Apnea Using Electromyography of the Muscles of the Mouth
BREATH: Breakthrough Research in Electromyography for the Assessment of Sleep-disordered BreaTHing
2 other identifiers
observational
60
1 country
1
Brief Summary
The investigators will establish how well a novel, quick, and painless way of measuring muscle activity from the mouth and throat works for detecting sleep apnea. This technology is called transmembraneous electromyography (tmEMG). Leveraging two technologies, a new probe capable of recording muscle activity by lightly touching the muscle, as well as a machine learning model for signal interpretation, the investigators will conduct an initial observational feasibility study in phase 1, followed by a larger observational cohort study in phase 2 to assess the performance of deep learning enhanced tmEMG. The study will address a critical unmet need in sleep apnea diagnostics: the availability of an inexpensive, accurate diagnostic test for screening at point of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 24, 2025
CompletedFirst Submitted
Initial submission to the registry
April 14, 2025
CompletedFirst Posted
Study publicly available on registry
April 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedApril 25, 2025
April 1, 2025
5 months
April 14, 2025
April 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AUC (Area Under the Curve)
Diagnostic accuracy, as measured by the area under the receiver operator characteristic curve (AUC), of DL-tmEMG algorithm in detecting moderate to severe OSA.
3 months
Secondary Outcomes (1)
Delta AUC When Adding Clinical Data
3 months
Study Arms (2)
Healthy Controls
Adults who have completed a sleep study but were not diagnosed with sleep apnea.
People with Sleep Apnea
Adults who have completed a sleep study and were diagnosed with sleep apnea.
Interventions
The transmembranous electromyography (tmEMG) probe is a disposable single-use bipolar recording device with the sensor configured with two electrodes located at the distal end of the probe in a parallel orientation. Unlike conventional EMG probes that are designed to be inserted into the muscle, the tmEMG probe is placed on the surface of the muscle similar to a surface electrode; the tip of the probe is approximately the size of a ball point pen, which allows us to record from the smaller muscles inside the mouth. Recordings will be taken from the genioglossus and palatoglossus in the mouth bilaterally. Recordings will be taken while the subject performs various maneuvers such as shallow breathing, deep breathing, and pressing their tongue against the side of their mouth.
Eligibility Criteria
Study subjects will be recruited from adult patients who have undergone a sleep study, generally within San Diego County.
You may qualify if:
- Age 18 years or older
- Subject must have completed a prior sleep test.
- Subjects may be recruited if the last prior sleep test either determined that they do not have sleep apnea OR they have moderate to severe sleep apnea. No sleep apnea is defined by AHI \< 5; moderate to severe sleep apnea is defined by AHI \>= 15.
- To be fully eligible, the prior test result needs to be verified via 2-night home sleep test (using the average AHI from the 2 nights). If OSA status (i.e., AHI\<5/h or \>=15/h) from the 2-night HST vs last prior sleep test is discordant, then participants will be excluded as screen failures.
You may not qualify if:
- Current use of OSA therapy, including PAP (positive airway pressure) or non-invasive ventilation on a daily basis
- Prior uvulopalatopharyngoplasty surgery for sleep apnea.
- Inability to install WatchPAT ONE application on smartphone or tablet or unwillingness/inability to use the WatchPAT ONE home sleep study device
- Prisoners are excluded due to ethical, legal, and practical concerns
- Individuals who are pregnant are excluded due to temporary changes in habitus, fluid shifts, and potential changes to oropharyngeal musculature may impact tmEMG assessment. This important subpopulation will be investigated in a later phase study.
- Inability to stop tobacco, marijuana, or vaping on the day of testing.
- Binge alcohol use behaviors (4+ drinks on the same occasion on 5+ days in the past month).
- Medication use that may cause central apnea that in the judgment of the investigators could impact the safety or results of the study
- Allergy to benzocaine topical anesthetic or other ester class local anesthetics (lidocaine, etc.)
- Current psychiatric illness other than treated mood disorders
- Unable or unwilling to provide informed consent or comply with research procedures
- Active Cancer due to potential interference with study results
- Major comorbidities which in the judgment of the investigators could impact the safety or results of the study
- Inability to sign consent and participate in the study in English. This study involves use of an investigational device; the technical nature of the study and the consenting process and consent form make it impractical to include subjects who cannot participate in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegolead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- Powell Mansfield Inc.collaborator
Study Sites (1)
University of California San Diego
San Diego, California, 92037, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jejo Koola, MD
University of California, San Diego
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
April 14, 2025
First Posted
April 25, 2025
Study Start
March 24, 2025
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share